(5-Cyanobenzofuran-2-yl)boronic acid, 95.0%, 100mg

4-N-Boc-2-oxo-piperazine-1-acetic acid, 97.0%, 250mg

7-Methoxyimidazo[1,2-a]pyridine, 97.0%, 25g

1-(3-hydroxypropyl)-4-sulfanylidene-1,2,3,4,5,6,7,8-octahydroquinazolin-2-one, 95.0%, 500mg

D-Tryptophan>98.0%(HPLC)(T)25g

N,N'-BIS(P-TOLUENESULFONYL)HYDRAZINE, 98.0%, 10g

N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-N'-[4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]urea, 98%, 25mg

tert-Butyl 2-cyano-7-azaspiro[3.5]nonane-7-carboxylate, 95.0%, 250mg

tri-Kaliumphosphat, min. 97 %, rein, wasserfrei, 500 g, kunststoffverpackung.

2-(Furan-2-yl)-7-(3-(4-methoxyphenyl)propyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, 95.0%, 5mg

2,6-Dichloro-N-phenylaniline, 95.0%, 100g

Gel-Blotting-Papiere, Whatman® 3MM, D 0,34 mm, 460 x 570 mm, , 100 Blatt

iScope IS.1154-PLi/T Biocular mit Plan IOS-Objektiven und Rackless-Kreuztisch (Face-to-Face-Duo-Kopf-System)